Furthermore, the DII seemed to be more robustly correlated with breast cancer with ER+/PR+ tumors than with ER−/PR− tumors, whereas premenopausal women did not show this association; the breast cancer risk according to DII score was significantly linked only to ER+/PR+ tumors in premenopausal women. The gene discussed is ESR1; the disease is breast cancer.